Cargando…

Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer’s disease and other tauopathies

Some aged community dogs acquire a degenerative syndrome termed Canine Cognitive Dysfunction (CCD) that resembles human dementia because of Alzheimer’s Disease (AD), with comparable cognitive and behavioral deficits. Dogs also have similar neuroanatomy, share our domestic environment and develop amy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abey, Ajantha, Davies, Danielle, Goldsbury, Claire, Buckland, Michael, Valenzuela, Michael, Duncan, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018065/ https://www.ncbi.nlm.nih.gov/pubmed/32810333 http://dx.doi.org/10.1111/bpa.12893

Ejemplares similares

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2015)

SHORT TELOMERES ASSOCIATE WITH HYPERPHOSPHORYLATED TAU BURDEN IN PRIMARY AGE-RELATED TAUOPATHY
por: McMillan, Corey, et al.
Publicado: (2022)

Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models
por: Selvarasu, Karthikeyan, et al.
Publicado: (2022)

Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization
por: Yadikar, Hamad, et al.
Publicado: (2020)

Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells
por: Chatterjee, Shreyasi, et al.
Publicado: (2019)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
por: Sinsky, Jakub, et al.
Publicado: (2021)

Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
por: Barron, Matthew R., et al.
Publicado: (2020)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2018)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
por: Ivanov, Stefan M., et al.
Publicado: (2020)

Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial
por: Valenzuela, Michael, et al.
Publicado: (2022)

Correction to: Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
por: Naini, Seyedeh Maryam Alavi, et al.
Publicado: (2020)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2020)

Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy
por: Trease, Andrew J., et al.
Publicado: (2022)

Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
por: Stefanoska, Kristie, et al.
Publicado: (2022)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Publicado: (2023)

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies
por: Florenzano, Fulvio, et al.
Publicado: (2017)

Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
por: Foidl, Bettina M., et al.
Publicado: (2018)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
por: Hines, Amelia D., et al.
Publicado: (2023)

The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease
por: Liu, Zhenzhen, et al.
Publicado: (2015)

Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease☆
por: Zheng, Xianhong, et al.
Publicado: (2012)

The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
por: Hobday, Amy L, et al.
Publicado: (2021)

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
por: Dong, Yue, et al.
Publicado: (2022)

“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
por: Xia, Yuxing, et al.
Publicado: (2021)

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
por: Pires, Geoffrey, et al.
Publicado: (2019)

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
por: Melov, Simon, et al.
Publicado: (2007)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

PINCH in the Cellular Stress Response to Tau-Hyperphosphorylation
por: Ozdemir, Ahmet Yunus, et al.
Publicado: (2013)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

Immunological memory to hyperphosphorylated tau in asymptomatic individuals
por: Pascual, Gabriel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cu2pca82halmndqse0rhejbv93